Comparison the effect of salbutamol via nebulizer, spray with and without spacer on pulmonary function in Chronic Obstructive Pulmonary Disease (COPD)

Gonabad University of Medical Sciences0 个研究点目标入组 66 人开始时间: 待定最近更新: 2021年5月26日

适应症

试验速览

暂无简介。

•Satisfaction to participate in research
•Abnormal spirometry test including 0.7= FEV1/FVC ratio
•Age of 40-75 years old
•Physical ability to perform spirometry maneuvers
•Lack of pregnancy
•With body mass index between 18.5 - 25
•Stages 1-4 of the disease based on GOLD criteria
•No specific intervention related to COPD or other possible diseases other than routine treatments
•Having awareness, the power of speech and communication
•Having a stable physiological state to answer questions
•No spirometry contraindications (uncontrolled blood pressure, infectious respiratory infection, active hemoptysis, recent eye or ear surgery, rupture of the tympanic membrane, recent history of CVA or pulmonary embolism, history of myocardial infarction or unstable angina in the last 6 weeks)

•Severely ill patients with COPD exacerbation with loss of consciousness or need for intubation
•Patients with comorbidity disorders such as heart failure, kidney, liver and diabetes
•Asthma, pneumonia and severe respiratory failure with cyanosis and confusion

发起方

Gonabad University of Medical Sciences